Endocrinology billing has a specific set of complexity factors, diabetes management codes, CGM and insulin pump coverage, thyroid procedures, and chronic care management. Each area has its own billing nuances, and each is an audit target in its own right. Get this wrong at volume and the cost shows up fast, through denials, undercoding, or missed follow-up.
If you're working through these issues, our specialty billing services can help you address them systematically.
Diabetes is the bread and butter of most endocrinology practices. Beyond the standard E&M visit, there are legitimate add-on revenue streams: Chronic Care Management (99490 series) for patients with multiple chronic conditions, and Principal Care Management (99424–99427) for patients with a single complex chronic condition.
PCM codes are specifically designed for conditions like uncontrolled diabetes with multiple complications, exactly the kind of patient an endocrinologist manages. The billing requirement is 30+ minutes of clinical staff time per month working on care management, outside of face-to-face visits. Document the time. Every minute, every month.
Continuous glucose monitor coverage under Medicare expanded significantly with the 2023 policy change that allows coverage for therapeutic CGM for any beneficiary with diabetes on insulin or at risk of hypoglycemia. The coding and billing pathway matters:
The professional analysis code 95251 is frequently underbilled in endocrinology. Every time you pull and review CGM data at a visit, that's a billable service, as long as you document the review and the time spent.
Insulin pump (continuous subcutaneous insulin infusion) management has its own E&M structure. The initiation involves training and programming that's separately billable. Ongoing pump management during visits can be captured through standard E&M, but the documentation needs to reflect the complexity of the management, not just "pump settings reviewed."
Thyroid ultrasound (76536) and thyroid biopsy under ultrasound guidance (10005, 10006 for FNA) are common endocrinology procedures. Ultrasound guidance billing requires documentation that the guidance was used, not just that the biopsy was done. The ultrasound guidance code is an add-on and should accompany the biopsy code, not stand alone.
Thyroid scan and uptake studies (78012–78018) have specific technical and professional components. If you're reading the results but a nuclear medicine facility is doing the scan, bill only the professional component with modifier -26.
Diabetes self-management training (DSMT) and medical nutrition therapy (MNT) are separately billable services that most endocrinology practices underuse. DSMT provides up to 10 hours of initial training and 2 hours of follow-up per year. MNT provides 3 hours initially, 2 hours follow-up. Both require a referral from the treating physician, a licensed/certified provider to deliver the service, and documentation of the education content and patient response.
Endocrinology visits often involve multiple complex chronic conditions and significant data review (labs, CGM tracings, medication adjustments). Under the 2021+ E&M guidelines, your MDM level should reflect the complexity of what you're actually doing. If you're managing uncontrolled Type 1 diabetes with nephropathy and retinopathy, a high-complexity MDM is likely justified, but your documentation has to show the number of problems, the data reviewed, and the risk of management decisions. Don't settle for a 99213 on patients you're spending 30 minutes managing complex disease states.
See how Rcmaxis handles the full scope of Endocrinology billing on our Endocrinology billing services page.
Endocrinology has three areas where reviewers look closely. Continuous glucose monitoring claims are checked against the patient's insulin use or hypoglycemia risk and the follow-up documentation. Chronic care management is checked for consent, a care plan, and time that adds up to the threshold. And ultrasound-guided biopsies are checked for evidence that the guidance was actually used, not just that a biopsy was done. Contractors can look back three years, and on a practice with a recurring pattern here, that lookback can put a large recoupment at stake, before the cost of the appeal.
Each of those is a documentation question rather than a coding question. Contractors can review three years of claims and extrapolate what they find, so a template that leaves out consent or the guidance record affects every patient it touched. Spot-check ten charts per area each quarter, and fix the template if the same element is missing more than once.
Endocrinology notes are full of data: A1c trends, glucose downloads, medication changes, and comorbidities. The MDM level depends on showing that work. Make sure the note lists the data reviewed, such as labs and CGM reports, and describes the decisions made. A statement like "reviewed 14-day CGM report, time in range low, adjusted basal rate" shows both the data and the decision.
Build that phrase structure into your template as a prompt, and providers will fill it in without extra effort. It supports the E/M level and the medical necessity for CGM and pump management in the same sentence.
Chronic care management and diabetes education are the two services endocrinology practices most often leave on the table. For each, create a simple trigger: at every visit, a staff member checks whether the patient qualifies and hasn't been offered the service. Record the answer. That check takes a few seconds and moves both services from occasional to routine.
Keep the compliance side simple too. Consent for CCM, referral documentation for education, and a time log for each. Once the workflow is set, the services support themselves.
Thyroid biopsies and ultrasounds are quick procedures with documentation requirements that are easy to skip. Once a quarter, pull a sample of ultrasound-guided biopsies and check for the elements: indication, guidance documentation, images retained, and a signed report. Fix any template gaps and record the result.
Keep a list of patients on CGM or insulin pumps with their next follow-up date, authorization status, and supply source. Review it monthly so that follow-up visits, which are often required to keep coverage, are scheduled and documented.
Endocrinology revenue sits in a handful of recurring codes. At 2026 Medicare non-facility rates, CGM interpretation (95251) pays $35.07, a thyroid ultrasound (76536) pays $108.55, ultrasound-guided fine needle aspiration (10005) pays $132.27 and chronic care management (99490) pays $66.13 per month.
Take a practice with 200 patients on CGM and 80 enrolled in CCM. Billing the interpretation monthly adds up to $84,168 a year, and CCM at one billable month per patient adds $63,485. A practice that captures only half of each loses about $73,826 a year.
The article describes a 2023 policy change that expanded therapeutic CGM coverage to beneficiaries with diabetes who use insulin or are at risk of hypoglycemia. Document the reason for the device and the follow-up, since coverage depends on it.
Ultrasound guidance can be billed when it's documented as used, not just when a biopsy is performed. The article points to 10005 and 10006 for FNA under ultrasound guidance and 76536 for thyroid ultrasound, and the guidance has to be part of the record.
Up to 10 hours of initial training and 2 hours of follow-up per year, according to the article. DSMT and MNT are separately billable, and most endocrinology practices underuse them.
The billing gaps most practices don't catch until they show up as denials. Get the checklist: free, no spam.
✓ Got it! Your info is saved: view the checklist now →
We don't share your info. Unsubscribe any time.
Revenue check: A quarterly sample of 20 to 30 claims here, checked against the supporting documentation, is cheap insurance against a $15,000 to $35,000 repayment surprise down the line.
Our team audits your RCM process end-to-end, no fluff, just the numbers that matter.
Request a Free Audit